Cargando…
Newborn Sickle Cell and Thalassaemia Screening Programme: Automating and Enhancing the System to Evaluate the Screening Programme
Good information is needed to demonstrate that a screening programme is meeting its objectives, to measure performance against standards and to ensure that action is taken if standards are not met. In 2010, the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme established a process to colle...
Autores principales: | Coppinger, Catherine, O’Loughlin, Robyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510245/ https://www.ncbi.nlm.nih.gov/pubmed/33072989 http://dx.doi.org/10.3390/ijns5030030 |
Ejemplares similares
-
Evaluation of newborn sickle cell screening programme in England: 2010–2016
por: Streetly, Allison, et al.
Publicado: (2018) -
Newborn screening in Nigeria: will incorporating congenital hypothyroidism with sickle cell disease improve neonatal screening programme?
por: Iroro, Enameguolo Yarhere, et al.
Publicado: (2019) -
Newborn Screening for Sickle Cell Disease in Europe
por: Daniel, Yvonne, et al.
Publicado: (2019) -
The Newborn Hearing Screening Programme in Germany
por: Matulat, Peter, et al.
Publicado: (2018) -
Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study
por: Nnodu, Obiageli E, et al.
Publicado: (2020)